IDT Biologika

IDT Biologika


Launch date
Employees
Market cap
-
Enterprise valuation
CAD526m (Public information from Jun 2024)
Saxony-Anhalt Germany (HQ)

  • Edit
DateInvestorsAmountRound
*

$243m

Valuation: $386m

Acquisition
Total Funding-

Recent News about IDT Biologika

Edit
More about IDT Biologika
Edit

IDT Biologika is a contract development and manufacturing organization with almost 100 years of experience in development and manufacture of live viral vaccines, gene and immune therapeutics, and fill/finish of biologics for the global protection of human health. With the expertise and capacity to handle large-scale campaign production of human vaccines and biopharmaceuticals, IDT Biologika brings development, testing and regulatory excellence along with state-of-the-art manufacturing lines required to advance projects with the highest level of quality, efficiency and consistency of supply. Recognized for its technically sophisticated contract development, manufacture and handling of biopharmaceuticals in EMA- and FDA-inspected facilities, IDT Biologika has developed into one of the world's leading pharmaceutical and biotechnological companies. The company's headquarters are located in Dessau-Rosslau , Germany. In the United States, IDT Biologika Corp. is responsible for sales activities throughout North America.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.